Several healthcare names were among Thursday's top gainers, led by Veru on a Novo Nordisk collaboration, Health Catalyst on the divestment of its revenue workflow and analytics software business, Absci ahead of clinical trial readouts, and Alvotech on another FDA application attempt. The news is broadly constructive for each company, but it is more event-driven than market-moving. Overall impact appears limited to individual stocks rather than the broader market.
Several healthcare names were among Thursday's top gainers, led by Veru on a Novo Nordisk collaboration, Health Catalyst on the divestment of its revenue workflow and analytics software business, Absci ahead of clinical trial readouts, and Alvotech on another FDA application attempt. The news is broadly constructive for each company, but it is more event-driven than market-moving. Overall impact appears limited to individual stocks rather than the broader market.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly positive
Sentiment Score
0.35
Ticker Sentiment
